Literature DB >> 1772962

Heart muscle antibodies in myasthenia gravis.

A Mygland1, J A Aarli, H Hofstad, N E Gilhus.   

Abstract

Myasthenia gravis (MG) may in some patients, especially in those with a thymoma, involve the heart. Using an ELISA, we measured heart muscle antibodies in sera from 75 MG patients and in 173 control sera. Heart muscle antibodies were detected in 29/30 thymoma MG patients, in none of 30 young onset MG patients with thymic hyperplasia and in 7/15 late onset MG patients with thymic atrophy. Among the controls, four sera had a very low concentration of heart muscle antibodies. Absorption studies showed that the heart muscle antibodies cross-react with skeletal muscle, but are unrelated to acetylcholine receptor antibodies.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1772962     DOI: 10.3109/08916939109001899

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  4 in total

1.  A case of myasthenia gravis with cardiac fibrosis and easily provoked sustained ventricular tachycardia.

Authors:  Aiko Sakamoto; Miyuki Yamamoto; Masao Takahashi; Kohsuke Ajiki; Satoshi Ota; Akimichi Murakami; Makoto Mutou; Kamon Imai; Takahiro Maruta; Hiroaki Yoshikawa; Nobukazu Ishizaka; Hiroshi Yamashita; Yasunobu Hirata; Ryozo Nagai
Journal:  J Cardiol Cases       Date:  2010-02-19

2.  Left ventricular long-axis function in myasthenia gravis.

Authors:  Jone Furlund Owe; Einar Skulstad Davidsen; Geir Egil Eide; Eva Gerdts; Nils Erik Gilhus
Journal:  J Neurol       Date:  2008-12-08       Impact factor: 4.849

3.  Total drug treatment and comorbidity in myasthenia gravis: a population-based cohort study.

Authors:  J B Andersen; J F Owe; A Engeland; N E Gilhus
Journal:  Eur J Neurol       Date:  2014-04-09       Impact factor: 6.089

Review 4.  Complicating autoimmune diseases in myasthenia gravis: a review.

Authors:  Aliona Nacu; Jintana Bunpan Andersen; Vitalie Lisnic; Jone Furlund Owe; Nils Erik Gilhus
Journal:  Autoimmunity       Date:  2015-04-27       Impact factor: 2.815

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.